Nectar Lifesciences Limited (NECLIFE)

Volume: 6,95,309Avg Vol 1W: 8,65,178.2Avg Vol 1M: 5,46,01652W Range:₹9.3₹23.87

₹13.64▼ 4.21%

Key Ratios

Market Cap₹229 Cr

Current Price₹13.64

Previous Close₹14.24

High / Low (52w)₹23.87 / ₹9.3

Volume6,95,309

Avg Vol (1W)8,65,178.2

Avg Vol (1M)5,46,016

Stock P/E—

Book Value₹25.96

Dividend Yield0%

ROE-9.8%

ROA-47.1%

Revenue (TTM)₹1,675 Cr

Revenue Growth-0.8%

Profit Margin-47.62%

Total Debt₹60 Cr

Shares Outstanding19 Cr

Face Value₹1

EPS (TTM)₹-3.38

P/B0.39

Debt / Equity0

50 DMA₹11.65

200 DMA₹14.79

Day change-4.21%

Price Chart

₹13.64▼ 40.72% · 1Y

2025-06-17

2026-05-11

20-day avg volume: 5.5L shares

Pros

Quarterly Results

Metric	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	₹359 Cr	₹6 Cr	₹0 Cr	₹0 Cr	₹5 Cr	₹1 Cr	₹0 Cr	₹1 Cr
EBITDA	₹25 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹-1 Cr	₹0 Cr	₹-1 Cr	₹-51 Cr
Net Profit	₹3 Cr	₹6 Cr	₹8 Cr	₹-130 Cr	₹-63 Cr	₹-176 Cr	₹14 Cr	₹-68 Cr
EPS	—	—	—	—	—	—	—	—

Profit & Loss (Annual)

Metric	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Revenue	₹2,371 Cr	₹1,547 Cr	₹1,680 Cr	₹1,567 Cr	₹1,699 Cr	₹1,675 Cr
EBITDA	₹163 Cr	₹53 Cr	₹113 Cr	₹37 Cr	₹105 Cr	₹-87 Cr
Net Profit	₹32 Cr	₹-73 Cr	₹25 Cr	₹-24 Cr	₹5 Cr	₹-114 Cr
EPS	—	—	—	—	—	—

Balance Sheet

Metric	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Total Assets	₹2,633 Cr	₹2,471 Cr	₹2,391 Cr	₹2,189 Cr	₹2,191 Cr	₹2,047 Cr
Total Liabilities	₹1,497 Cr	₹1,409 Cr	₹1,303 Cr	₹1,125 Cr	₹1,122 Cr	₹1,091 Cr
Equity	₹1,136 Cr	₹1,062 Cr	₹1,088 Cr	₹1,065 Cr	₹1,069 Cr	₹956 Cr
Total Debt	₹121 Cr	₹128 Cr	₹291 Cr	₹226 Cr	₹140 Cr	₹60 Cr

Cash Flow

Metric	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Operating	₹294 Cr	₹25 Cr	₹95 Cr	₹134 Cr	₹225 Cr	₹169 Cr
Investing	₹-33 Cr	₹-29 Cr	₹17 Cr	₹52 Cr	₹-17 Cr	₹-42 Cr
Financing	₹-252 Cr	₹11 Cr	₹-119 Cr	₹-186 Cr	₹-205 Cr	₹-128 Cr
Free Cash Flow	₹294 Cr	₹25 Cr	₹95 Cr	₹134 Cr	₹225 Cr	₹169 Cr

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search